dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Zacarias Fluck, Mariano F |
dc.contributor.author | Soucek, Laura |
dc.contributor.author | Whitfield, Jonathan |
dc.date.accessioned | 2024-03-26T07:18:03Z |
dc.date.available | 2024-03-26T07:18:03Z |
dc.date.issued | 2024-03-06 |
dc.identifier.citation | Zacarías-Fluck MF, Soucek L, Whitfield JR. MYC: there is more to it than cancer. Front Cell Dev Biol. 2024 Mar 6;12:1342872. |
dc.identifier.issn | 2296-634X |
dc.identifier.uri | https://hdl.handle.net/11351/11241 |
dc.description | MYC; Malalties no oncològiques; Factor de transcripció |
dc.description.sponsorship | The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. Authors acknowledge funding support from the Spanish Ministry of Science and Innovation (Fondo de Investigación en Salud [FIS] PI19/01277, the State Agency for Research (Agencia Estatal de Investigación) as a Center of Excellence Severo Ochoa (CEX 2020-001024-S/AEI/10.13039/501100011033), the Generalitat de Catalunya (AGAUR 2021/SGR 01509), and the FERO foundation. |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Cell and Developmental Biology;12 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Factors de transcripció - Inhibidors |
dc.subject | Farmacologia molecular |
dc.subject | Malalties |
dc.subject.mesh | Transcription Factors |
dc.subject.mesh | /antagonists & inhibitors |
dc.subject.mesh | Molecular Targeted Therapy |
dc.title | MYC: there is more to it than cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fcell.2024.1342872 |
dc.subject.decs | factores de transcripción |
dc.subject.decs | /antagonistas & inhibidores |
dc.subject.decs | terapia molecular selectiva |
dc.relation.publishversion | https://doi.org/10.3389/fcell.2024.1342872 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Zacarías-Fluck MF, Whitfield JR] Models of Cancer Therapies Laboratory, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona. Spain. [Soucek L] Models of Cancer Therapies Laboratory, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. Peptomyc S.L., Barcelona, Spain |
dc.identifier.pmid | 38510176 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F01277 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |